Safety of COVID-19 vaccination in children with prior allergic reactions or mast cell disorders.
作者信息
Kulkarni Rishabh, Arnold Annabelle, Buzynski Adrian, Lucas Michaela
机构信息
Immunology Department, Sir Charles Gairdner Hospital, Perth, Western Australia.
Medical School, University of Western Australia, Perth, Western Australia.
出版信息
Clin Transl Allergy. 2023 May;13(5):e12267. doi: 10.1002/clt2.12267.
Abstract
摘要
相似文献
1
Safety of COVID-19 vaccination in children with prior allergic reactions or mast cell disorders.
Clin Transl Allergy. 2023 May;13(5):e12267. doi: 10.1002/clt2.12267.
2
Allergic Reactions to COVID-19 Vaccination in High-Risk Allergic Patients: The Experience of Trieste University Hospital (North-Eastern Italy).
Vaccines (Basel). 2022 Sep 27;10(10):1616. doi: 10.3390/vaccines10101616.
3
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations.
Vaccines (Basel). 2021 Mar 5;9(3):221. doi: 10.3390/vaccines9030221.
4
Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review.
J Cosmet Dermatol. 2022 Jan;21(1):4-12. doi: 10.1111/jocd.14613. Epub 2021 Nov 17.
5
Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
JAMA Netw Open. 2021 Oct 1;4(10):e2131034. doi: 10.1001/jamanetworkopen.2021.31034.
6
Anaphylaxis is a rare reaction in COVID-19 vaccination.
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):839-842. doi: 10.23812/BELLOMO_EDIT_3_21.
7
Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
Vaccine. 2021 Jul 22;39(32):4404-4406. doi: 10.1016/j.vaccine.2021.06.061. Epub 2021 Jun 25.
8
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2139-2144. doi: 10.1016/j.jaip.2021.03.041. Epub 2021 Apr 5.
9
Allergic Reactions to Vaccines in Children: From Constituents to Specific Vaccines.
Biomedicines. 2023 Feb 18;11(2):620. doi: 10.3390/biomedicines11020620.
10
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
Vaccine. 2021 Oct 22;39(44):6464-6469. doi: 10.1016/j.vaccine.2021.09.048. Epub 2021 Sep 28.
本文引用的文献
1
Primary care is the ideal setting to promote COVID-19 vaccination for children.
Med J Aust. 2022 Dec 12;217(11):575-577. doi: 10.5694/mja2.51769. Epub 2022 Nov 20.
2
Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.
Allergy. 2023 Jan;78(1):71-83. doi: 10.1111/all.15571. Epub 2022 Nov 23.
3
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.
Vaccines (Basel). 2022 May 4;10(5):718. doi: 10.3390/vaccines10050718.
4
Second dose of COVID-19 vaccination in immediate reactions to the first BNT162b2.
Pediatr Allergy Immunol. 2022 Jan;33(1):e13683. doi: 10.1111/pai.13683. Epub 2021 Nov 2.
5
Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.
JAMA Intern Med. 2021 Nov 1;181(11):1530-1533. doi: 10.1001/jamainternmed.2021.3779.
6
Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome.
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3198-3199. doi: 10.1016/j.jaip.2021.05.010. Epub 2021 May 24.
7
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
J Allergy Clin Immunol. 2021 Jun;147(6):2075-2082.e2. doi: 10.1016/j.jaci.2021.04.002. Epub 2021 Apr 20.
8
EAACI position paper: skin prick testing in the diagnosis of occupational type I allergies.
Allergy. 2013;68(5):580-4. doi: 10.1111/all.12120. Epub 2013 Feb 15.
Zotero 插件